The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling
Open Access
- 6 February 2020
- journal article
- research article
- Published by Springer Nature in Blood Cancer Journal
- Vol. 10 (2) , 1-14
Abstract
Large-scale chromosomal translocations are frequent oncogenic drivers in acute myeloid leukemia (AML). These translocations often occur in critical transcriptional/epigenetic regulators and contribute to malignant cell growth through alteration of normal gene expression. Despite this knowledge, the specific gene expression alterations that contribute to the development of leukemia remain incompletely understood. Here, through characterization of transcriptional regulation by the RUNX1-ETO fusion protein, we have identified Ras-association domain family member 2 (RASSF2) as a critical gene that is aberrantly transcriptionally repressed in t(8;21)-associated AML. Re-expression of RASSF2 specifically inhibits t(8;21) AML development in multiple models. Through biochemical and functional studies, we demonstrate RASSF2-mediated functions to be dependent on interaction with Hippo kinases, MST1 and MST2, but independent of canonical Hippo pathway signaling. Using proximity-based biotin labeling we define the RASSF2-proximal proteome in leukemia cells and reveal association with Rac GTPase-related proteins, including an interaction with the guanine nucleotide exchange factor, DOCK2. Importantly, RASSF2 knockdown impairs Rac GTPase activation, and RASSF2 expression is broadly correlated with Rac-mediated signal transduction in AML patients. Together, these data reveal a previously unappreciated mechanistic link between RASSF2, Hippo kinases, and Rac activity with potentially broad functional consequences in leukemia.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (F31CA189452, R01CA104509)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
This publication has 62 references indexed in Scilit:
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- The phenotype of human STK4 deficiencyBlood, 2012
- Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in miceThe EMBO Journal, 2012
- Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemiaBlood, 2011
- The Ras Effector RASSF2 Controls the PAR-4 Tumor SuppressorMolecular and Cellular Biology, 2010
- Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liverProceedings of the National Academy of Sciences, 2010
- Combined Immunodeficiency Associated withDOCK8MutationsNew England Journal of Medicine, 2009
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migrationNature, 2001